Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Alna Technology is a specialized biotechnology company focused on the production and supply of high-quality reagents for peptide synthesis. Based in Beijing, the company provides a comprehensive range of products including protected amino acids, resins, linkers, and coupling reagents essential for solid-phase peptide synthesis (SPPS). Alna Technology serves a global clientele comprising pharmaceutical companies, biotechnology firms, and academic research institutions. By maintaining rigorous quality control standards, the company supports drug discovery and development efforts in the peptide and protein therapeutic sectors. Their expertise in chemical synthesis allows them to offer custom synthesis services tailored to specific research needs. The company is recognized as a reliable partner in the life sciences supply chain, facilitating the advancement of peptide-based medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Alna Technology.